Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 10 Prostatic Neoplasms 7 Sarcoma 4 Uterine Cervical Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 3 Pancreatic Neoplasms 3 Carcinoma, Intraductal, Noninfiltrating 3 Urinary Bladder Neoplasms 2 Endometrial Neoplasms 2 Cholangiocarcinoma 2 Carcinoma, Non-Small-Cell Lung 2 Breast Carcinoma In Situ 2 Urologic Neoplasms 1 Urologic Diseases 1 Urogenital Neoplasms 1 Urogenital Diseases 1 Urinary Bladder Diseases 1 Triple Negative Breast Neoplasms 1 Small Cell Lung Carcinoma 1 Sarcoma, Ewing 1 Prostate Adenocarcinoma 1 Pituitary Neoplasms 1 Neurilemmoma 1 Nerve Sheath Neoplasms 1 Neoplasms by Site 1 Neoplasms 1 Neoplasm Metastasis 1 Meningioma 1 Male Urogenital Diseases 1 Lymphedema 1

Interventions

Temozolomide 12 Vincristine 9 Irinotecan 8 Cyclophosphamide 8 cabozantinib 6 X-Rays 5 Specimen Handling 5 Magnetic Resonance Spectroscopy 5 Etoposide 5 regorafenib 4 fludarabine 4 Radiotherapy 4 Phantoms, Imaging 4 Ifosfamide 4 Doxorubicin 4 Radiation 3 ulixertinib 2 tipifarnib 2 tazemetostat 2 selpercatinib 2 palbociclib 2 olaparib 2 liposomal doxorubicin 2 ivosidenib 2 irinotecan sucrosofate 2 etoposide phosphate 2 abemaciclib 2 Zoledronic Acid 2 Topotecan 2 Surgical Procedures, Operative 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Sarcoma, Ewing × Radiation Dose Hypofractionation × 1 year × Clear all

NCT07188532 2026-06-04

BEAR

Mayo Clinic

Phase NA Recruiting

Sarcoma, Ewing

Data powered by HemOnc (CC BY 4.0) Colophon ⚡